Searching for rare diseases in PubMed: a blind comparison of Orphanet expert query and query based on terminological knowledge by Griffon, Nicolas et al.
Searching for rare diseases in PubMed: a blind
comparison of Orphanet expert query and query based
on terminological knowledge
Nicolas Griffon, Matthieu Schuers, Ferdinand Dhombres, Tayeb Merabti,
Gaetan Kerdelhue´, Laetitia Rollin, Stefan Darmoni
To cite this version:
Nicolas Griffon, Matthieu Schuers, Ferdinand Dhombres, Tayeb Merabti, Gaetan Kerdelhue´,
et al.. Searching for rare diseases in PubMed: a blind comparison of Orphanet expert query
and query based on terminological knowledge. BMC Medical Informatics and Decision Making,
BioMed Central, 2015, 16 (1), pp.101. <10.1186/s12911-016-0333-0>. <inserm-01350880>
HAL Id: inserm-01350880
http://www.hal.inserm.fr/inserm-01350880
Submitted on 2 Aug 2016
HAL is a multi-disciplinary open access
archive for the deposit and dissemination of sci-
entific research documents, whether they are pub-
lished or not. The documents may come from
teaching and research institutions in France or
abroad, or from public or private research centers.
L’archive ouverte pluridisciplinaire HAL, est
destine´e au de´poˆt et a` la diffusion de documents
scientifiques de niveau recherche, publie´s ou non,
e´manant des e´tablissements d’enseignement et de
recherche franc¸ais ou e´trangers, des laboratoires
publics ou prive´s.

RESEARCH ARTICLE Open Access
Searching for rare diseases in PubMed: a
blind comparison of Orphanet expert query
and query based on terminological
knowledge
N. Griffon1,2* , M. Schuers1,3, F. Dhombres2,4, T. Merabti1, G. Kerdelhué1, L. Rollin1,5 and S. J. Darmoni1,2
Abstract
Background: Despite international initiatives like Orphanet, it remains difficult to find up-to-date information about
rare diseases. The aim of this study is to propose an exhaustive set of queries for PubMed based on terminological
knowledge and to evaluate it versus the queries based on expertise provided by the most frequently used resource
in Europe: Orphanet.
Methods: Four rare disease terminologies (MeSH, OMIM, HPO and HRDO) were manually mapped to each other
permitting the automatic creation of expended terminological queries for rare diseases. For 30 rare diseases,
30 citations retrieved by Orphanet expert query and/or query based on terminological knowledge were assessed
for relevance by two independent reviewers unaware of the query’s origin. An adjudication procedure was used
to resolve any discrepancy. Precision, relative recall and F-measure were all computed.
Results: For each Orphanet rare disease (n = 8982), there was a corresponding terminological query, in contrast
with only 2284 queries provided by Orphanet. Only 553 citations were evaluated due to queries with 0 or only a
few hits. There were no significant differences between the Orpha query and terminological query in terms of
precision, respectively 0.61 vs 0.52 (p = 0.13). Nevertheless, terminological queries retrieved more citations more
often than Orpha queries (0.57 vs. 0.33; p = 0.01). Interestingly, Orpha queries seemed to retrieve older citations
than terminological queries (p < 0.0001).
Conclusion: The terminological queries proposed in this study are now currently available for all rare diseases.
They may be a useful tool for both precision or recall oriented literature search.
Keywords: PubMed, Rare diseases, Bibliography as topic, Terminology as topic
Background
There is currently no consensual definition of what is a
rare disease: in Europe, a disease is considered rare if it
affects less than 1 in 2000 citizens, while in United States
of America (USA), the threshold was set at 200,000 in the
entire population [1] (approximately 1 in 1600 according
to the USA census bureau [2]).
These gross definitions lead to a major heterogeneity
between rare diseases:
 Most of genetic diseases are rare diseases, but some
infectious diseases, cancer and auto-immune
diseases are also rare.
 They may occur at any point in life
 There are geographical variations. A disease may be
rare in one country (like Periodic disease in France)
but quite frequent in another (Periodic disease in
Armenia)
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 Some are well known and have been described for a
number of years, whereas some have been recently
discovered and information is scarce.
Furthermore, these definitions have led to the knowledge
of 5000 to 8000 rare diseases and to the “paradox of rarity”:
each disease is rare, but patients with rare diseases are nu-
merous. Having a clear vision of the prevalence of rare dis-
eases is not an easy task, nevertheless, it is commonly
accepted that approximately 5 to 10 % of the population
suffer from rare diseases (8–9 % in the USA [1], 6–8 % in
the European Union [3]). In both regions, this corresponds
to approximately 30,000,000 patients suffering from a rare
disease, making it a real public health concern [4].
This heterogeneity and frequency of rare diseases
translates into numerous different situations in which
some information is needed:
 Finding a physician with adequate experience may
be easy when a reference center exists, but can be a
real difficulty if care pathways are not identified [5]
 Providing medical care for patients with a rare
disease is a difficult task for physicians. Even if the
care episode does not concern the rare disease.
 Writing a systematic review about a rare diseases, or
doing a short review in order to write a research
article, requires querying one or more bibliographic
databases with as much relevant keywords as
possible [6].
It seems of public health importance to provide all
these participants with the appropriate tools to easily
retrieve relevant information about rare diseases.
PubMed is one of the most popular search engines to
access medical literature. It browses the MEDLINE biblio-
graphic database, which gathers a large part of biomedical
scientific articles, and some other minor resources [7].
MEDLINE is indexed using the MeSH® thesaurus. Al-
though PubMed theoretically allows to access the literature
about rare diseases, including the most recent scientific
discoveries, the combination of the following elements
may hinder users:
 the relative novelty of MeSH terms for rare diseases
[8]. Until 2010, the MeSH contained only a few rare
diseases, also, citations pertaining to rare diseases
published before 2010 are not indexed precisely for
rare diseases. Since this date, 10,354 rare diseases, as
defined by the Office of Rare Diseases Research
(ORDR) [9], have been introduced in MeSH
(source MeSH 2014),
 the delay in article MeSH-indexing in PubMed [10],
which can be several weeks to several months,
according to the importance of the journal, and
 the health professionals, or the lay-persons, lack of
knowledge about MeSH [11].
It is therefore difficult for physicians, and furthermore
patients, to query Pubmed in an effective way, and
especially to find an article about rare diseases published
before 2010 or in recent months.
Several institutions (Genetic and Rare Diseases In-
formation Center [12] and Orphanet [13]) already
gather information on their website about rare dis-
eases including a brief summary, clinical information
and many links to other resources. Sometimes a link
to a PubMed expert based query is provided, limiting
users task to citation relevance assessment. Neverthe-
less, in the case of Orphanet these queries do not
always take advantage of all the MeSH/PubMed func-
tionalities and they are far from providing a compre-
hensive coverage of all rare diseases. Moreover, the
methodology of establishing these queries is not dis-
closed on the Orphanet website. The aim of this study
was to propose a set of queries linked to each rare disease
term in Orphanet and to evaluate these queries against
those developed by Orphanet.
Methods
PubMed overview
PubMed is the most frequently used bibliographic data-
base used by biomedical scientist throughout the world.
It therefore constitute a standard in terms of informa-
tion retrieval. MEDLINE is the major component of
PubMed, gathering almost 90 % of the 26 millions of
PubMed citations. MEDLINE curators affect to each cit-
ation a list of MeSH terms to describe it with a con-
trolled level of granularity. The MeSH atomic part is the
MeSH concept, a class of synonymous terms – i.e. all
terms gathered in a MeSH concept are true synonyms.
MeSH concepts closely related to each other in
meaning may be gathered in a MeSH descriptor
(MeSH D) or a MeSH supplementary concept (MeSH
SC), one of them being the prefered concept, and the
other being narrower, broader or related to the pre-
ferred one. Both MeSH D and MeSH SC aims at
indexing the citation, but they exhibit some differ-
ences. First, MeSH SC are quite specific terms: they
are used to index chemicals, drugs, and other con-
cepts such as rare diseases. Second, MeSH SC, unlike
MeSH D, are not classed, they are only linked to one
or more MeSH D, usually broader, by a specific rela-
tionship. Lastly, there are a lot more MeSH SC (≈200,000)
than MeSH D (≈27,000).
Pubmed users may specify what search field they
want to use in their query using between-bracket op-
erators. Table 1 presents some operators and their
meaning.
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PubMed queries
Orpha queries
Orphanet PubMed queries were manually created by
Orphanet experts. These queries are available on the
Orphanet web site (URL: www.orpha.net), on each disease
page (for the diseases that have an Orphanet PubMed
query, of course). For exemple, for the Orphanet concept
“retroperitoneal fibrosis”, the PubMed query is: retrope-
ritoneal fibrosis[majr] OR Retroperitoneal fibrosis[ti]. For
the orphanet concept “Blount disease”, the query is:
Blount disease[tw] OR tibia vara[tw].
Terminological queries
In addition to the MeSH thesaurus, several other ter-
minologies and ontologies are available on rare diseases:
(a) a formal ontology named HRDO (Human Rare
Disease Ontology) [14] was developed based on the
Orphanet classification. This ontology is available in five
European languages: English, French, German, Spanish
and Portuguese; (b) the Online Mendelian Inheritance in
Man (OMIM) database, developed at Johns Hopkins Uni-
versity [15]; (c) the Human Phenotype Ontology (HPO), a
formal ontology, which allows the description in an unam-
biguous fashion of phenotypic information in medical
publications and databases [16]. The HPO is freely avail-
able at http://www.human-phenotype-ontology.org.
One of the authors (SJD) has created exact match
mappings between MeSH, OMIM, HPO and HRDO
based on a natural language processing/conceptual based
algorithm [17, 18] suggestions. Exact match mapping
means that the two concepts are real synonyms (e.g. the
“Absent corpus callosum cataract immunodeficiency”
MeSH concept and the “Vici syndrome” HRDO disease).
Using these alignments, PubMed queries are created
automatically, according to a published algorithm [19].
The algorithm output depends on the type of MeSH
term mapped to: MeSH concept, MeSH SC or MeSH D
(see Table 2 for examples):
a) If the HRDO concept is mapped to a MeSH Descriptor,
the query structure is as follows:
Disease[MH] OR Disease[TW] OR Synonyms Disease
MeSH Descriptor[TW] OR Synonyms Disease
HRDO[TW] OR Synonyms Disease OMIM[TW]
(if an exact match mapping exists between HRDO
concept and OMIM concept) OR Synonyms Disease
HPO[TW] (if an exact match mapping exists between
HRDO concept and HPO concept)
Table 1 Some operators used in PubMed
Operator Meaning
[ti] The term is considered as a free text keyword and
searched for in title
[ab] The term is considered as a free text keyword and
searched for in abstract
[mh] The term, a MeSH descriptor, and all the terms it
subsumes, are searched for in MeSH indexing
[majr] The term, a MeSH descriptor, and all the terms it
subsumes, are searched for in MeSH major indexing
[nm] The term, a MeSH supplementary concept, is searched
for in MeSH indexing
[tw] The term is considered as a free text keyword and
searched for in multiple fields of PubMed citation
(title, abstract, MeSH indexing, other keywords etc.)
Table 2 Exemples of queries according to the type of the MeSH term mapped to the HRDO concept
Types of mapped MeSH terms
MeSH descriptor MeSH supplemetary concept MeSH concept Not a MeSH term
HRDO concept example “retinal dystrophy” “Omenn syndrome” “Charcot-Marie-Tooth
disease, type ib”
“Isolated oxycephaly”
MeSH part of the query “retinal dystrophies”[MH] OR
“retinal dystrophies”[TW] OR
“dystrophies, retinal”[TW] OR
“dystrophy, retinal”[TW]
OR “retinal dystrophy”[TW] OR
“reticuloendotheliosis, familial,
with eosinophilia”[NM] OR
“reticuloendotheliosis, familial,
with eosinophilia”[TW] OR
“severe combined immunodeficiency
with hypereosinophilia”[TW] OR
“Charcot-Marie-Tooth
disease, type ib”[TW]
OR “1B, HMSN”[TW]
OR “1Bs, HMSN”[TW] OR
-
HRDO part of the query “Retinal dystrophy”[TW] OR “Omenn syndrome”[TW] OR
“Combined immunodeficiency
with hypereosinophilia”[TW] OR
“Charcot-Marie-Tooth
disease type 1B”[TW]
OR “CMT1B”[TW] OR
“Isolated oxycephaly”[TW]
OR “Turricephaly”[TW] OR
“Nonsyndromic oxycephaly”
[TW] OR
HPO part of the query “Retinal dystrophy”[TW] - - “Turricephaly”[TW]
OMIM part of the query - “Omenn syndrome”[TW] “Charcot-marie-tooth
disease, demyelinating,
type 1b”[TW]
-
Each column contains one example of PubMed query corresponding to the HRDO concept in the “HRDO concept example” row. Each row gathers all the
synonyms for the considered diseases in one terminology. The final queries are composed by every synonyms of every terminologies, linked by “OR”. The final
PubMed query for the Isolated oxycephalydisease is: “Turricephaly”[TW] OR “Nonsyndromic oxycephaly”[TW] OR “Isolated oxycephaly”[TW]. The last “OR”
“turricephaly” is redundant. In this case, the final query is deducible from only one terminology (HRDO)
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b) If the HRDO concept is mapped to a MeSH
Supplementary Concept, the query structure
is as follows:
Disease[NM] OR Disease[TW] OR Synonyms
Disease MeSH Supplemntary Concept[TW] OR
Synonyms Disease HRDO[TW] OR Synonyms
Disease OMIM[TW] OR Synonyms Disease
HPO[TW]
c) If the HRDO concept is mapped to a MeSH Concept,
the query structure is as follows:
Disease[TW] OR Synonyms Disease MeSH
Concept[TW] OR Synonyms Disease HRDO[TW]
OR Synonyms Disease OMIM[TW] OR Synonyms
Disease HPO[TW]
d) And if the HRDO concept is not mapped to the
MeSH thesaurus, the query structure is as follows:
Disease[TW] OR Synonyms Disease HRDO[TW]
OR Synonyms Disease OMIM[TW] OR Synonyms
Disease HPO[TW]
Relevance evaluation
Thirty rare diseases were randomly selected from the
subset with both an Orphanet query and a termino-
logical query. The selected rare diseases are listed in
Table 4 (at the end of the document). The diseases with
a prevalence higher than 1/2000 were considered as not
rare. One author (GK) gathered the first ten citations re-
trieved (PubMed “recently added” ranking), for each rare
disease, using the following queries:
Q1 ¼ QOrpha AND QTerm ð1Þ
Q2 ¼ QOrpha NOT QTerm ð2Þ
Q3 ¼ QTerm NOT QOrpha ð3Þ
With QOrpha the Orpha query and QTerm the termino-
logical query. Therefore, Q1 retrieved citations common
to both Orpha and terminological query, Q2 retrieved
citations specific to the Orpha query and Q3 retrieved
citations specific to the terminological query. He (GK)
then hid the retrieving query: the evaluators were
blinded vs. the type of query. The anonymised citations
were split between four physicians (FD, LR, MS and
NG) in such way that: (i) each citation was evaluated
twice and, (ii) each evaluator shared each third of their
evaluations with one different evaluator.
Evaluators had to answer the following question for
each citation: “Does the article directly concern the dis-
ease?” In case of any disagreement, a third evaluator
evaluated the citation and the discrepancy was resolved
by consensus.
More information regarding relevance evaluation is
available in Additional file 1.
Statistical analysis
Agreement between evaluators was measured by kappa.
HRDO rare diseases may be split into two: terms with
an Orpha query and terms without Orpha query. These
two sub-populations were compared according to avail-
able determinants to ensure generalizability.
For each rare disease, it is possible to estimate the pre-
cision (pi) of each query (Q1, Q2, Q3; see Eq. 4).
pi ¼ n relQi
 
=n evalQi
  ð4Þ
With n(relQi) and n(evalQi) the number of relevant cit-
ation and the number of evaluated citation for the query
i, respectively. Orpha queries and terminolgical queries
were compared according to micro average precision,
number and publication date of retrieved citations, and
use of MeSH terms. Non-parametric tests were used:
Fisher’s test for qualitative variables (micro average preci-
sion and MeSH use) and Wilcoxon test and Kruskal-
Wallis test for quantitative variables (number of citation
and date). The Dunn test allows pairwise comparison after
Kruskal-Wallis.
Results
HRDO, in its 09/11/2013 version, inventory 9060 dis-
eases and groups of diseases. Seventy-eight were not
considered as rare diseases because the prevalence, as
specified by Orphanet, was above the European thresh-
old, also, the study considered only the 8982 rare dis-
eases. Table 3 lists the number of alignments created or
validated by SJD.
Only 2284 HRDO rare diseases have a manually vali-
dated Orphanet query (25.4 %). A terminological query
is generated for each disease in Orphanet (was it rare or
not). Orpha queries and terminological queries respect-
ively retrieved 0 citations in 5 (<1 %) and 4370 (48.7 %)
cases (see Fig. 1). Considering both “no query” and “0 cita-
tions” situations, there is a useful terminological or Orpha
queries for 51.3 or 25.4 % of HRDO rare diseases,
respectively.
The 30 selected rare diseases and the number of
citations retrieved by each query are listed in Table 4.
Terminological queries retrieved more citations more
often than Orpha queries (17 terminological queries
Table 3 Number of exact match mappings created between
the different terminologies considered
MeSH HPO OMIM
Descriptor Supplementary Concept Concept
HRDO 1247 2620 3837 484 2707
OMIM 550 4019 4681 296
HPO 886 157 1131
For example, SJD has created 1247 synonymy mappings between an HRDO
concept and a MeSH descriptor
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retrieved more results than Orpha queries while only 10
orpha queries retrieved more results than terminological
queries; p = 0.01; Wilcoxon test). As some queries re-
trieved less than 10 citations (see Table 4), only 553
PubMed citations were assessed for relevance (instead of
30 × 3 × 10 = 900). Kappa indexes before the adjudication
procedure range from moderate (0.41) to almost perfect
(0.86) agreement. Overall kappa was 0.68 (substantial
agreement).
The precision of each query, computed after adjudi-
cation process, are listed in Table 4. The intersection
query (Q1) is significantly more precise than Q2 (p = 0.01;
Fisher’s test) and Q3 (p < 0.001; Fisher’s test). However,
there was no significant difference between Q2 and Q3
precision (0.61 vs. 0.52, respectively; p = 0.13; Fisher test).
For the 30 selected diseases, there was significantly more
terminological query that fully used the MeSH thesaurus
(28 vs. 8; p < 0.001; Fisher’s test; data not shown).
When considering relevant citations alone, it is
noteworthy that citations retrieved by Q2 (i.e. only by
orpha queries) are significantly older than those re-
trieved by Q1 and Q3 (p < 0.0001 in both cases,
Dunn’s test with Bonferroni correction). Median pub-
lication dates are 2013, 2005 and 2014 for Q1, Q2 and
Q3, respectively. The results are very similar when consid-
ering all the citations evaluated, whether they were rele-
vant or not.
Discussion
There is no differences between Orpha and termino-
logical queries in terms of precision. However, Orpha
queries retrieved significantly fewer results. Moreover,
citations retrieved only by Orpha queries are signifi-
cantly older than citations retrieved by terminological
queries, and, Orphanet provides queries for only 25.4 %
of rare diseases while terminological queries retrieved at
least one PubMed citation for 51.3 % rare diseases. This
suggests a differentiated approach according to the user
objectives:
 a precision-interested user should use the
intersection query, which will retrieve the most
relevant citations,
 a recall-interested user might be interested in the
union query.
Nevertheless, for almost 75 % of HRDO rare disease,
there is no other solution but the terminological query.
Physicians are probably more interested in precision
than in recall. A researcher, in contrast, may be more in-
terested in recall for their literature review. However, in
many cases, only the terminological query is available
leaving the user no choice. A potentially interesting use
of the set of terminological queries is its use to find
medical experts about rare diseases [5], where noise is a
less important problem. The set of terminological quer-
ies is available from the Health Terminology Ontology
Portal [20] (URL: http://www.hetop.eu).
Two mechanisms may explain the more up to date set
of results retrieved by terminological query: (i) the major
part of the difference is a consequence of the evaluation
method. As terminological queries retrieve more results
than orphanet queries, we can hypothesized that there is
both more recent and more older citations. However,
PubMed ranks recent results first and we only evaluated
the first ten results – i.e. the more recent. (ii) Some key-
words added by the terminology expansion are quite re-
cent, and not yet taken into account by orphanet expert
in their queries.
While these hypotheses limit the value of the up-to-
date effect of terminological query, it raises a mainten-
ance issue. Creating and maintaining a query is very
time-consuming and it is probably one of the main limi-
tation of Orphanet query. For terminological queries,
the maintenance may only be necessary when terminolo-
gies evolve. For example, Vasilevsky et al. [21] recently
enhanced HPO with terms that patients, doctors, and
machines can all understand. This evolution will require
a limited validation maintenance for terminological
Fig. 1 Distribution of queries according to the number of citations retrieved for Orphanet and terminological queries
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queries. However, the convergence of these terminolo-
gies (with the Orphanet Rare Diseases Ontology [22])
may ultimately importantly reduce the maintenance
tasks.
Strengths and limitations
Only two sets of queries were compared in this study:
one from the Orphanet [13] and one based on termin-
ologies [20]. The queries from the Genetic and Rare
Diseases Information Center [12] were not tested for this
study because of their limited design (they often only
rely on OMIM record references [23], which are not up-
dated on a regular basis). In fact, these queries cannot
retrieve any citation that has not been considered by the
OMIM authors. The added-value against the OMIM rec-
ord references is therefore very limited. Also, only two
set of queries may be considered as gold standard for a
terminology queriescomparison: Orpha query and free
text queries, which most users are likely to submit. They
both present pros and cons.
Using free text query sounds like a very pragmatic
approach, close to the reality. Results would be easy to
Table 4 Number of citations retrieved and precision for each query, by diseases
Disease MeSH level alignment n(retr) Precision
Q1 Q2 Q3 p1 p2 p3
3M syndrome SC 38 5 31 1 0.4 0.4
Autosomal recessive hypohidrotic ectodermal dysplasia D 25 21 12 0.8 0.4 0.8
Generalized epilepsy - paroxysmal dyskinesia SC 0 18 6 – 0.5 0.17
Silent sinus syndrome – 107 2 3 1 1 0.67
Toluene embryopathy SC 8 39 0 1 0.2 –
Familial drusen SC 67 54 9 1 0.1 0.78
Autoimmune lymphoproliferative syndrome D 176 5 1800 1 1 0
Diphtheria D 4419 0 13,149 1 – 0.6
Hypomandibular faciocranial dysostosis SC 6 2 0 0.83 1 –
Retroperitoneal fibrosis D 1986 0 711 1 – 0.6
Epstein syndrome SC 41 0 0 1 – –
Oculopharyngeal muscular dystrophy D 291 31 129 0.9 1 0.6
Ring chromosome 19 SC 6 4 2 1 0.75 1
Nephropathy - deafness - hyperparathyroidism SC 0 1 0 – 1 –
Greenberg dysplasia SC 7 4 6 1 1 0.83
Menkes disease D 968 0 47,026 1 – 0
Mikati-Najjar-Sahli syndrome – 0 1 0 – 1 –
Genochondromatosis SC 5 0 0 1 – –
Noonan syndrome D 1483 0 258 0.8 – 0.5
Carney complex D 248 21 299 0.9 1 0.7
Blount disease SC 296 0 6 0.5 – 1
Oculocerebrofacial syndrome, Kaufman type SC 5 0 0 1 – –
Wilson disease D 5266 0 1231 1 – 0.8
Adult Still’s disease D 1129 0 202 1 – 0.8
Esophageal atresia D 2999 75 479 0.9 1 0.6
Congenital nephrotic syndrome, Finnish type C 8 239 43 0.88 0.8 0.1
Thiamine-responsive megaloblastic anemia syndrome SC 69 34 39 1 0.6 0.1
Hereditary myoclonus - progressive distal muscular atrophy SC 0 2 0 – 0.5 –
Dentatorubral-pallidoluysian atrophy C 361 171 215 0.9 0 0.6
Neuronal ceroid lipofuscinosis D 1371 0 1379 1 – 0.5
Macro average precision 0.81 0.44 0.41
Micro average precision 0.94 0.61 0.52
n(retr) number of citations retrieved, D MeSH Descriptor, SC MeSH Supplementary Concept, C MeSH Concept
Griffon et al. BMC Medical Informatics and Decision Making  (2016) 16:101 Page 6 of 8
interpret. Nevertheless, it is difficult to establish due to
the impossibility of formalizing such a gold standard.
The label choice has a major influence over the query
result: if a label from the MeSH is used, PubMed will
automatically recognize the MeSH term and perform a
semantic expansion, otherwise, the query may be toke-
nized and each term searched for separately, which
would introduce a lot of noise.
Using Orpha query may seem questionnable: only
25.4 % of the rare disesases are provided with a query
and query production processus is unclear. However,
these queries are somewhat validated by Orphanet ex-
pert and they are available online.
For these reasons, the use of Orpha query as a gold
standard seemed to be preferable. The question the eval-
uators have to answer for each citation is quite generic
and it might not be adapted to the real users context.
One difficulty is to reach an acceptable inter evaluator
agreement, the only way to assess the quality of the rele-
vance assessment. A more specific question was tested:
“Is the citation useful for medical care?” but agreement
was very low.
The main limitation of this study is probably the qual-
ity assurance of terminology mapping: relying on one ex-
pertise is not sufficient for sensitive data, and while the
help of an automatic algorithm may limit the false posi-
tive rate at the same time it also increases the false nega-
tive rate. Also, proper quality assurance might probably
have slightly enhance terminological query performance.
Nevertheless, the results presented in our study, with no
difference in precision, demonstrate that a sufficient
high mapping quality was achieved.
This study demonstrates some strengths. First, the
evaluation of citations by two independant physicians
unaware of the query and the adjudication procedure
render the judgement as reliable and unbiased as pos-
sible. Second, the results are theoretically generalizable
because of the random selection of the diseases, which
led to a similar distribution of disease prevalence in the
studied corpus compared to the entire HRDO.
The main strength of the terminological approach pre-
sented here is the availability of a query for each rare
disease in each terminology. The cost of this approach –
maintenance of mapping – seems very limited. Queries
take advantage of the rich synonymy of classifications
(HPO, HRDO, OMIM, MeSH), and, when there is an
alignment to MeSH, of MeSH indexing. The semantic
expansion used here could be enhanced using UMLS,
nevertheless, this resource has already been shown to be
too noisy [24].
Query structure - MeSH
Orpha queries and terminological queries are structur-
ally different. Terminological queries are based on the
automatic exploitation of terminological knowledge,
therefore the queries are structurally simple, i.e. all the
keywords are linked by a “OR” in the query. Orpha
query, as manually designed, may be more complex, im-
plying all the boolean operators (AND, OR and NOT).
Even if an exact match MeSH term does not exist it is
possible to use a combination of MeSH terms relevant
to the disease. Overall, as previously mentioned above,
the creation and maintenance of Orpha queries is a
much more time consuming task.
MeSH use is also problematic because of the nov-
elty of rare disease MeSH terms [8]. Therefore, de-
cades of citations about rare diseases are only
indexed using free text and MeSH term recall is ne-
cessarily low. Nevertheless, the indexing of citations
with MeSH will gradually increase, enhancing the re-
call of queries based on MeSH terms, the mapping
between Orphanet diseases and MeSH terms is there-
fore important to maintain.
Conclusions
There is a terminological query for each rare disease.
This query precision was not statistically different from
the precision found for Orpha queries. The termino-
logical queries proposed in this study are a useful tool
for both precision or recall oriented literature search in
combination with the Orpha query, if available.
Additional file
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